| pubmed-article:20633187 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20633187 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20633187 | lifeskim:mentions | umls-concept:C0378482 | lld:lifeskim |
| pubmed-article:20633187 | lifeskim:mentions | umls-concept:C1332828 | lld:lifeskim |
| pubmed-article:20633187 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
| pubmed-article:20633187 | lifeskim:mentions | umls-concept:C0205175 | lld:lifeskim |
| pubmed-article:20633187 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20633187 | pubmed:dateCreated | 2010-7-16 | lld:pubmed |
| pubmed-article:20633187 | pubmed:abstractText | The prospective study was designed to clarify the impact of CYP2C19 on quadruple therapies and survey the efficacies of rabeprazole-based quadruple therapy for Helicobacter pylori infection after failure of standard triple therapies. | lld:pubmed |
| pubmed-article:20633187 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20633187 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20633187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20633187 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20633187 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:20633187 | pubmed:issn | 1523-5378 | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:HsuPing-IPI | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:HungWen-ChunW... | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:YangYuan-Chie... | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:KuoChao-HungC... | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:WuDeng-Chyang... | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:WangWen-MingW... | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:ChenAngelaA | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:KuoFu-ChenFC | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:LiChia-JungCJ | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:WengBi-Chuang... | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:HsuWen-HungWH | lld:pubmed |
| pubmed-article:20633187 | pubmed:author | pubmed-author:WangSophie... | lld:pubmed |
| pubmed-article:20633187 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20633187 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:20633187 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20633187 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20633187 | pubmed:pagination | 265-72 | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:meshHeading | pubmed-meshheading:20633187... | lld:pubmed |
| pubmed-article:20633187 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20633187 | pubmed:articleTitle | Rabeprazole can overcome the impact of CYP2C19 polymorphism on quadruple therapy. | lld:pubmed |
| pubmed-article:20633187 | pubmed:affiliation | Division of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan. | lld:pubmed |
| pubmed-article:20633187 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20633187 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:20633187 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:1557 | entrezgene:pubmed | pubmed-article:20633187 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20633187 | lld:entrezgene |
